Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers.
Linklater ES, Tovar EA, Essenburg CJ, Turner L, Madaj Z, Winn ME, Melnik MK, Korkaya H, Maroun CR, Christensen JG, Steensma MR, Boerner JL, Graveel CR.
Linklater ES, et al. Among authors: boerner jl.
Oncotarget. 2016 Oct 25;7(43):69903-69915. doi: 10.18632/oncotarget.12065.
Oncotarget. 2016.
PMID: 27655711
Free PMC article.